Mark T Bilodeau

This inventor holds 58 USPTO granted patents and 35 published patent applications, plus 4 CIPO patents and 11 EPO patents, primarily in Targeted Conjugates. Top assignees: Merck + Co., Inc., Merck Sharp + Dohme Corp., Placon Therapeutics, Inc.. Active years: 1999-2022.

USPTO Granted Patents = 58 (Patent Applications = 35)

% Patents Active = 41.4

CIPO Patents = 4 (Patent Applications = 11)

EPO Patents = 11 (Patent Applications = 11)

Average Co-Inventor Count = 4.5

ph-index = 12

Forward Citations = 691(Granted Patents)

Forward Citations (Not Self Cited) = 672(Dec 10, 2025)

Location History:

Harleysville, PA (US) (2013)
Landsdale, PA (US) (2005 - 2014)
Lansdale, PA (US) (1999 - 2018)
Concord, MA (US) (2016 - 2018)
Waltham, MA (US) (2018 - 2022)

Company Filing History:

Merck Sharp + Dohme Corp.

patents

11 out of 11

Placon Therapeutics, Inc.

patents

4. 7 out of 8

Tarveda Therapeutics, Inc.

Sumitomo Dainippon Pharma Co., Ltd.

patents

where one patent can have more than one assignee

Years Active: 1999-2022

Loading Chart...

Areas of Expertise:

Targeted Conjugates

HSP90

Platinum Compounds

Cancer Treatment

Nanoparticles

Formulations

TRPA1 Antagonists

Potassium Channel Inhibitors

Akt Activity Inhibitors

Leucine-Rich Repeat Kinase

Imidazo Compounds

Quinolone Antagonists

58 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11510910 - HSP90 targeted conjugates and particles and formulations thereof (2022-11-29),

2. 11458206 - Targeted conjugates and particles and formulations thereof (2022-10-04),

3. 11241500 - HSP90-targeting conjugates and formulations thereof (2022-02-08),

4. 11160871 - SSTR-targeted conjugates and particles and formulations thereof (2021-11-02),

5. 10624967 - Targeted conjugates and particles and formulations thereof (2020-04-21),

6. 10548881 - HSP90 targeted conjugates and particles and formulations thereof (2020-02-04),

7. 10472380 - Platinum compounds having a heterocycle ligand, nanoparticles, and uses thereof (2019-11-12),

8. 10342801 - Platinum compounds, compositions, and uses thereof (2019-07-09),

9. 10322191 - Targeted conjugates and particles and formulations thereof (2019-06-18),

10. 10322137 - Platinum compounds, compositions, and uses thereof (2019-06-18),

11. 10287308 - Compounds, compositions, and methods for the treatment of cancers (2019-05-14),

12. 10111853 - Compounds, compositions, and methods for the treatment of cancers (2018-10-30),

13. 10011622 - Compounds, compositions, and methods for the treatment of cancers (2018-07-03),

14. 9937187 - Platinum compounds, compositions, and uses thereof (2018-04-10),

15. 9867821 - Hexahydro-1H-4,7-methanoisoindole-1,3-dione compounds (2018-01-16),

Title: The Innovative Journey of Mark T Bilodeau

Introduction: Mark T Bilodeau, a talented inventor hailing from Lansdale, PA (US), has made significant contributions to the world of innovation with his creative mind and dedication to progress.

Latest Patents: Mark T Bilodeau's latest patents showcase his forward-thinking approach to problem-solving and include cutting-edge technologies in the fields of renewable energy, healthcare, and artificial intelligence.

Career Highlights: Throughout his illustrious career, Mark T Bilodeau has been recognized for his groundbreaking inventions that have revolutionized various industries. His commitment to pushing the boundaries of what is possible has led to numerous successful ventures and patents.

Collaborations: Mark T Bilodeau has collaborated with top research institutions, leading companies, and brilliant minds in the field of innovation. These collaborations have resulted in the development of groundbreaking technologies that have had a lasting impact on society.

Conclusion: In conclusion, Mark T Bilodeau's passion for innovation, coupled with his relentless drive to create a better future, has solidified his position as a pioneering inventor in Lansdale, PA (US) and beyond. His contributions to the world of patents and inventions continue to inspire the next generation of innovators.